Literature DB >> 7890754

Identification of the ubiquinone-binding domain in QPs1 of succinate-ubiquinone reductase.

G Y Lee1, D Y He, L Yu, C A Yu.   

Abstract

An azidoubiquinone derivative, 3-azido-2-methyl-5-methoxy [3H]-6-decyl-1,4-benzoquinone ([3H]azido-Q), was used to study the ubiquinone-protein interaction and to identify ubiquinone-binding proteins in bovine heart mitochondrial succinate-ubiquinone reductase. When the reductase was incubated with [3H]azido-Q and illuminated with long wavelength UV light, the decrease in the enzymatic activity correlated with the amount of azido-Q incorporated into the protein. When the illuminated, [3H]azido-Q-treated reductase was extracted with organic solvent and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, radioactivity was found primarily in the QPs1 subunit. The [3H]azido-Q-labeled QPs1 was purified from labeled reductase by a procedure involving ammonium sulfate fractionation, dialysis, organic solvent extraction, lyophilization, preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and cold acetone precipitation. The purified, [3H]azido-Q-labeled QPs1 protein was subjected to reductive carboxymethylation prior to digestion by trypsin. One azido-Q-linked peptide, with a retention time of 66.9 min, was obtained by high performance liquid chromatographic separation. The partial amino-terminal sequence of this peptide is GLTISQL-, indicating that this tryptic peptide comprises amino acid residues 113-140 of the revised amino acid sequence of QPs1. The Q-binding domain, using the proposed structure of QPs1, is probably located in the stretch connecting transmembrane helices 2 and 3 that extrude from the surface of the M side of the inner membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890754     DOI: 10.1074/jbc.270.11.6193

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Identification of a ubiquinone-binding site that affects autophosphorylation of the sensor kinase RegB.

Authors:  Lee R Swem; Xing Gong; Chang-An Yu; Carl E Bauer
Journal:  J Biol Chem       Date:  2006-01-05       Impact factor: 5.157

2.  Peroxynitrite-mediated oxidative modifications of complex II: relevance in myocardial infarction.

Authors:  Liwen Zhang; Chwen-Lih Chen; Patrick T Kang; Vivek Garg; Keli Hu; Kari B Green-Church; Yeong-Renn Chen
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

3.  Design and use of peptide-based antibodies decreasing superoxide production by mitochondrial complex I and complex II.

Authors:  Patrick T Kang; June Yun; Pravin P T Kaumaya; Yeong-Renn Chen
Journal:  Biopolymers       Date:  2011       Impact factor: 2.505

4.  Characterization of the ubiquinone binding site in the alternative NADH-quinone oxidoreductase of Saccharomyces cerevisiae by photoaffinity labeling.

Authors:  Masatoshi Murai; Tetsuo Yamashita; Mai Senoh; Yuko Mashimo; Michihiko Kataoka; Hiroaki Kosaka; Akemi Matsuno-Yagi; Takao Yagi; Hideto Miyoshi
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

5.  Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex II in the post-ischemic myocardium.

Authors:  Chwen-Lih Chen; Jingfeng Chen; Sharad Rawale; Saradhadevi Varadharaj; Pravin P T Kaumaya; Jay L Zweier; Yeong-Renn Chen
Journal:  J Biol Chem       Date:  2008-08-05       Impact factor: 5.157

6.  Genes encoding the same three subunits of respiratory complex II are present in the mitochondrial DNA of two phylogenetically distant eukaryotes.

Authors:  G Burger; B F Lang; M Reith; M W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

7.  Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors.

Authors:  Li-Shar Huang; Peter Lümmen; Edward A Berry
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2021-06-03       Impact factor: 4.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.